--- title: "Compugen (CGEN) stock listing, news and investor profile" url: "https://aibio.space/companies/compugen/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Compugen Ltd. (NASDAQ: CGEN), Israel. The directory classifies it as Biotechnology. Listing facts, related biotech companies and news on aibio.space." --- CGEN Compugen Ltd. NASDAQ · Israel # Compugen (CGEN) news Compugen Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CGEN, recorded under Israel. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Compugen news We have not published a story on Compugen yet. When there is news, it will appear here. ## Compugen at a glance - **Ticker**: CGEN - **Listing**: NASDAQ - **Country**: Israel - **Cash, Dec 31, 2025**: $99.9 million ### Related companies - [Matricelf](https://aibio.space/companies/matricelf/) TASE: MTLF - [Chemomab Therapeutics](https://aibio.space/companies/chemomab-therapeutics/) NASDAQ: CMMB - [Regentis Biomaterials](https://aibio.space/companies/regentis-biomaterials/) AMEX: RGNT - [NRGENE TECHNOLOGIES LTD](https://aibio.space/companies/nrgene-technologies/) TASE: NRGN - [Pluri](https://aibio.space/companies/pluri/) NASDAQ: PLUR - [Polyrizon](https://aibio.space/companies/polyrizon/) NASDAQ: PLRZ - [Enlivex](https://aibio.space/companies/enlivex/) NASDAQ: ENLV - [Kamada](https://aibio.space/companies/kamada/) NASDAQ: KMDA ### Also on NASDAQ - [biote](https://aibio.space/companies/biote/) BTMD - [YD Bio](https://aibio.space/companies/yd-bio/) YDES - [BioRestorative Therapies](https://aibio.space/companies/biorestorative-therapies/) BRTX - [XORTX Therapeutics](https://aibio.space/companies/xortx-therapeutics/) XRTX - [Seer](https://aibio.space/companies/seer/) SEER - [Karyopharm Therapeutics](https://aibio.space/companies/karyopharm-therapeutics/) KPTI ## Compugen annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$72.8 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | [$27.9 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | | Research and development | [$22.8 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | [$24.8 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | | Net income (loss) | [$35.3 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | [-$14.2 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | | Cash from operations | [$31.6 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | [$49.6 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | | Cash and equivalents | [$90.6 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | [$18.2 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | | Short-term investments | [$9.3 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | [$23.6 million](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $90.6 million, plus short-term investments of $9.3 million, $99.9 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Compugen What is the ticker symbol of Compugen? Compugen Ltd. trades under the ticker CGEN on NASDAQ. Where is Compugen listed? Compugen Ltd. is listed on NASDAQ. Our directory also records these other listings: TASE:CGEN. What is the SEC CIK of Compugen? The SEC Central Index Key (CIK) for Compugen Ltd. is 1119774. Its filings are on SEC EDGAR. How many shares does Compugen have outstanding? 94,553,191 shares as of 2025-12-31, per the cover page of its 20-F filed 2026-03-02. Which country or territory is Compugen listed under? Our directory records Compugen Ltd. under Israel. What does Compugen do? Our directory classifies Compugen Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Compugen? The ISIN recorded for Compugen Ltd. is IL0010852080. Does aibio.space cover Compugen? aibio.space lists Compugen Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Compugen incorporated? SEC records list its state or country of incorporation as L3. What was Compugen's revenue last year? $72.8 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Compugen profitable? Compugen Ltd. reported net income of $35.3 million for the fiscal year ended Dec 31, 2025, and generated $31.6 million of cash from operations, per its annual report to the SEC. How much does Compugen spend on research and development? $22.8 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Compugen have? $99.9 million in cash and short-term investments at Dec 31, 2025, per its 20-F. Is Compugen a smaller reporting company? SEC records list Compugen Ltd.'s filer category as: Accelerated filer. Where is Compugen headquartered? SEC records list its business address as 26 HAROKMIM STREET, HOLON, Israel, 5885849. ## Investor discussion: Compugen Members talk about Compugen (CGEN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:CGEN on TradingView](https://www.tradingview.com/symbols/NASDAQ-CGEN/). ## SEC filings and registration - **SEC name**: Compugen Ltd - **CIK**: 1119774 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: CGEN (Nasdaq) - **State or country of incorporation**: L3 - **Fiscal year ends**: December 31 - **Filer category**: Accelerated filer - **Business address**: 26 HAROKMIM STREET, HOLON, Israel, 5885849 - **Phone**: 011-972-3-765-8585 - **Shares outstanding**: 94,553,191 as of 2025-12-31 (20-F filed 2026-03-02) ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891326004494/zk2636108.htm) filed 2026-09-10 - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891326003756/zk2635809.htm) filed 2026-08-03 - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891326003754/zk2635762.htm) filed 2026-08-03 - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891326002750/zk2635352.htm) filed 2026-05-18 - [20-F](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm) filed 2026-03-02 - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000661/zk2634467.htm) filed 2026-03-02 - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000430/zk2634349.htm) filed 2026-02-12 - [6-K](https://www.sec.gov/Archives/edgar/data/1119774/000117891325004077/zk2534122.htm) filed 2025-12-17 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001119774), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Compugen Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CGEN, recorded under Israel. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Compugen Ltd. - **Ticker**: CGEN - **Listing**: NASDAQ - **Country or territory**: Israel - **Business scope**: Biotechnology - **ISIN**: IL0010852080 - **Other listed symbols**: TASE:CGEN - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-CGEN/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/compugen/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Compugen (CGEN) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/compugen/